Skip to main content
. 2013 May 22;8(5):e63775. doi: 10.1371/journal.pone.0063775

Figure 1. Representative flow cytometric analysis of the percentage of MDSCs in PBMCs in asthma patients, budesonide-treated asthma patients, healthy controls and pneumonia patients Inline graphic.

Figure 1

(A) Percentage of MDSCs (CD11b+/CD33+) in PBMCs in the normal group. (B) Percentage of MDSCs in PBMCs in the attack asthma group. (C) Percentage of MDSCs in PBMCs in the budesonide treated group. (D) Percentage of MDSCs in PBMCs in the pneumonia group.